Insiders Eagle Pharmaceuticals, Inc.

Equities

EGRX

US2697961082

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
4.55 ^USD	+1.56%		+15.19%	-13.00%

15/05	Eagle Pharmaceuticals, Inc. Enters into a Third Amendment to Third Amended and Restated Credit Agreement	CI
06/05	North American Morning Briefing : Stock Futures -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eagle Pharmaceuticals CFO Resigns; Shares Fall	11/03	MT
Eagle Pharmaceuticals, Inc. Announces Board and Committee Changes	09/03	CI
Wells Fargo Taps JPMorgan Alum for Vice Chairman	27/02	DJ
Eagle Pharmaceuticals, Inc. Announces Resignation of Scott Tarriff as Chief Executive Officer	29/11	CI
Eagle Pharmaceuticals, Inc. Announces Management Change	29/11	CI
Eagle Pharmaceuticals Insider Sold Shares Worth $300,026, According to a Recent SEC Filing	05/23/05	MT
Insider Sell: Eagle Pharmaceuticals	19/23/19	MT
Eagle Pharmaceuticals Announces Separation of Michael Moran as Chief Commercial Officer	19/22/19	MT
Michael Moran Separates as Executive Vice President, Chief Commercial Officer of Eagle Pharmaceuticals, Inc	19/22/19	CI
Eagle Pharmaceuticals, Inc. Appoints Debra M. Hussain as Senior Vice President, Head of Commercial	18/22/18	CI
Judith Ng-Cashin Separates as Executive Vice President, Chief Medical Officer of Eagle Pharmaceuticals, Inc	27/21/27	CI
Eagle Pharmaceuticals, Inc. Announces Executive Changes	01/21/01	CI
Eagle Pharmaceuticals, Inc. Appoints Luciana Borio to its Board of Directors	03/21/03	CI
Eagle Pharmaceuticals, Inc. Announces Management Changes	02/20/02	CI
Eagle Pharmaceuticals, Inc. Announces Resignation of Adrian J. Hepner as Executive Vice President and Chief Medical Officer, Effective July 31, 2020	17/20/17	CI
Eagle Pharmaceuticals Announces Departure of Douglas L. Braunstein from Board of Directors	14/19/14	CI
Eagle Pharmaceuticals, Inc. Appoints Jennifer K. Simpson as Director	04/19/04	CI
Eagle Pharmaceuticals, Inc. Appoints David Pernock as Chief Operating Officer	27/18/27	CI
Eagle Pharmaceuticals : Named to Fortune 100 List of Fastest-Growing Companies	23/18/23	BU
Eagle Pharmaceuticals, Inc. Terminates the Employment of Steven L. Krill as Executive Vice President and Chief Scientific Officer, Effective February 26, 2018	23/18/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Eagle Pharmaceuticals, Inc.

Equities

EGRX

US2697961082

Insiders

Filters